IL17A and myeloid sarcoma: Additionally, compared to healthy controls, MS patients exhibited a considerably higher number of CD40+CD4+ T cells (Th40), which were mostly memory phenotypic cells acting as an intermediary between Th1 and Th17 phenotypes and producing IL-17 and IFN-γ with a considerable portion of them simultaneously [187].